slides · global inventory
Show Traction
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 11,828
Current window 6,721-6,750
Pages 395
Rows per page 30
Slide function
6,721-6,750 of 11,828
09
The slide uses a circular process diagram to illustrate the feedback loop between data, AI, and wet lab validation.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
14
The slide highlights the efficacy of the company's de novo design model by comparing it against a known benchmark (trastuzumab).Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
15
Case study slide demonstrating model specificity and performance improvement over existing biological datasets.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
23
Case study slide showing correlation metrics (Pearson, Spearman, RMSE) and a histogram comparing predicted affinity to Trastuzumab.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
26
The slide uses a histogram to visualize the distribution of binding affinity (-log10(KD)) for designed variants compared to the wild-type Trastuzumab baseline.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
30
Includes a biological diagram of TLS and a Kaplan-Meier survival curve.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
32
The slide highlights key performance indicators of their antibody discovery platform and the disease areas they are targeting.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
33
The slide uses a two-column layout to contrast the partners (left) with the value derived from those partnerships (right).Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
38
The slide uses a bar chart to show relative expression across different nsAA incorporation counts, alongside a structural model of the antibody.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
43
The slide uses a mix of imagery and key metrics to establish credibility.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
44
Uses authority-citation to build credibility.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
11
The slide uses two semi-logarithmic line charts to compare drug concentration decay over time.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
23
The slide uses two distinct chart types to demonstrate potency (dose-response curve) and diversity (scatter plot of IC50 vs Relative DcR3/DR3 Blocking).Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit
11
Pharmacokinetic study results showing extended half-life for the drug candidate.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · Evidence & Proof1 hit
35
The slide combines financial runway with a clinical development timeline.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit
13
The slide displays longitudinal clinical trial data for a drug candidate (Imdusiran) across various dosing regimens (Cohorts E, F, I, J, G, K).Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product1 hit
14
Clinical trial data showing individual patient responses over time, including two cases of NA retreatment.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product1 hit
15
Data presented at EASL 2022. Shows longitudinal patient data for patients 42, 43, and 48.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product1 hit
18
The slide uses a timeline-based process diagram to illustrate the clinical trial randomization and treatment arms.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
22
Includes two distinct charts: a bar chart showing IFN-y fold increase and a line chart showing tumor volume reduction over time.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
15
The slide uses a list-based layout to present three distinct performance metrics.Astra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations Beat · Traction1 hit
08
Includes two distinct charts: a scatter/error bar plot for Phase 1 and a bar chart for the Canine Model.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
09
The slide demonstrates an inverted U-shaped dose response curve.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
10
Includes Cohen's d effect sizes and qEEG data markers.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
07
The slide uses a grid of images with captions to illustrate operational progress.VinFast | Investor Presentation Deck | 33 slides · VinFast
Pitch deck Investor relations 1 hit
08
The slide uses a 'Challenge-Solution' framework paired with a stacked bar chart to visualize operational milestones.VinFast | Investor Presentation Deck | 33 slides · VinFast
Pitch deck Investor relations 1 hit
10
The slide uses a grid of testimonials and press clippings alongside a photo collage to build social proof.VinFast | Investor Presentation Deck | 33 slides · VinFast
Pitch deck Investor relations Loop · Why Now1 hit
14
Includes a stock price chart and key performance metrics from the listing day.VinFast | Investor Presentation Deck | 33 slides · VinFast
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
15
Slide highlights both domestic marketing traction (Vietnam exhibition) and international operational milestones (NC factory, shipments, European retail expansion).VinFast | Investor Presentation Deck | 33 slides · VinFast
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
16
The slide uses a grid of big numbers to highlight scale and progress.VinFast | Investor Presentation Deck | 33 slides · VinFast
Pitch deck Investor relations Loop · Cost Of Inaction1 hit